Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 404

1.

p16 is consistently expressed in endometrial tubal metaplasia.

Horree N, Heintz AP, Sie-Go DM, van Diest PJ.

Cell Oncol. 2007;29(1):37-45.

PMID:
17429140
[PubMed - indexed for MEDLINE]
2.

Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.

Horrée N, Gort EH, van der Groep P, Heintz AP, Vooijs M, van Diest PJ.

J Pathol. 2008 Jan;214(1):38-45.

PMID:
17985331
[PubMed - indexed for MEDLINE]
3.

Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis.

Horrée N, van Diest PJ, van der Groep P, Sie-Go DM, Heintz AP.

Cell Oncol. 2007;29(3):219-27.

PMID:
17452774
[PubMed - indexed for MEDLINE]
4.

Progressive derailment of cell cycle regulators in endometrial carcinogenesis.

Horrée N, van Diest PJ, van der Groep P, Sie-Go DM, Heintz AP.

J Clin Pathol. 2008 Jan;61(1):36-42. Epub 2007 May 4.

PMID:
17483252
[PubMed - indexed for MEDLINE]
5.

The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators.

Horrée N, van Diest PJ, Sie-Go DM, Heintz AP.

Hum Pathol. 2007 Aug;38(8):1232-8. Epub 2007 May 8.

PMID:
17490724
[PubMed - indexed for MEDLINE]
6.

Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas.

Cao QJ, Einstein MH, Anderson PS, Runowicz CD, Balan R, Jones JG.

Int J Gynecol Pathol. 2002 Apr;21(2):147-54.

PMID:
11917224
[PubMed - indexed for MEDLINE]
7.

Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.

Ozbudak IH, Karaveli S, Simsek T, Erdogan G, Pestereli E.

Gynecol Oncol. 2008 Mar;108(3):603-8. doi: 10.1016/j.ygyno.2007.11.028. Epub 2008 Jan 11.

PMID:
18191183
[PubMed - indexed for MEDLINE]
8.

Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu LS, Ronnett BM.

Am J Surg Pathol. 2009 Oct;33(10):1504-14. doi: 10.1097/PAS.0b013e3181ac35f5.

PMID:
19623034
[PubMed - indexed for MEDLINE]
9.

Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands.

Stewart CJ, Crook ML, Leung YC, Platten M.

Mod Pathol. 2009 May;22(5):725-33. doi: 10.1038/modpathol.2009.33. Epub 2009 Mar 6.

PMID:
19270644
[PubMed - indexed for MEDLINE]
Free Article
10.

Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.

An HJ, Lee YH, Cho NH, Shim JY, Kim JY, Lee C, Kim SJ.

Histopathology. 2002 Nov;41(5):437-45.

PMID:
12405911
[PubMed - indexed for MEDLINE]
11.

Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.

Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA.

Mod Pathol. 2006 Aug;19(8):1091-100. Epub 2006 Apr 28.

PMID:
16648864
[PubMed - indexed for MEDLINE]
Free Article
12.

Immunohistochemical detection of cyclin A with reference to p53 expression in endometrial endometrioid carcinomas.

Shiozawa T, Xin L, Nikaido T, Fujii S.

Int J Gynecol Pathol. 1997 Oct;16(4):348-53.

PMID:
9421074
[PubMed - indexed for MEDLINE]
13.

p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium.

Horn LC, Richter CE, Einenkel J, Tannapfel A, Liebert UG, Leo C.

Ann Diagn Pathol. 2006 Aug;10(4):193-6.

PMID:
16844559
[PubMed - indexed for MEDLINE]
14.

Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).

Ozkara SK, Corakci A.

Pathol Oncol Res. 2004;10(2):89-97. Epub 2004 Jun 9.

PMID:
15188025
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.

Ruhul Quddus M, Latkovich P, Castellani WJ, James Sung C, Steinhoff MM, Briggs RC, Miranda RN.

Arch Pathol Lab Med. 2002 Apr;126(4):459-63.

PMID:
11900573
[PubMed - indexed for MEDLINE]
17.

Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.

Nishimura Y, Watanabe J, Jobo T, Kato N, Fujisawa T, Kamata Y, Kuramoto H.

Anticancer Res. 2004 Jul-Aug;24(4):2185-91.

PMID:
15330159
[PubMed - indexed for MEDLINE]
Free Article
18.

p16 expression in the female genital tract and its value in diagnosis.

O'Neill CJ, McCluggage WG.

Adv Anat Pathol. 2006 Jan;13(1):8-15. Review.

PMID:
16462152
[PubMed - indexed for MEDLINE]
19.

Expression of the cell cycle regulators p53, p21(WAF1/CIP1) and p16(INK4a) in human endometrial adenocarcinoma.

Buchynska LG, Nesina IP.

Exp Oncol. 2006 Jun;28(2):152-5.

PMID:
16837908
[PubMed - indexed for MEDLINE]
20.

Hypoxia contributes to development of recurrent endometrial carcinoma.

Pijnenborg JM, Wijnakker M, Hagelstein J, Delvoux B, Groothuis PG.

Int J Gynecol Cancer. 2007 Jul-Aug;17(4):897-904. Epub 2007 Mar 13.

PMID:
17359291
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk